The nanoparticle protein corona has potential to enrich disease monitoring and detect biomarkers. Here, the authors report on a nano-omics investigation of changes in plasma and tumour tissue proteins associated with glioblastoma and demonstrate biomarker discovery in mouse models and patient cohorts.
- Xinming Liu
- Hanan Abmanhal-Masarweh
- Marilena Hadjidemetriou